Skip to main content
. 2018 Apr 12;8:5885. doi: 10.1038/s41598-018-24156-x

Figure 1.

Figure 1

Targets Selected for Analysis of Aberrant Alternative Splicing. Three categories of alternative exons selected are shown: early responding exons (INSR E11 and SOS1 E25); medium responding exons (CACNA1S E29, ANK2 E21, PHKA E28 and MBNL1 E7), and late responding exons (KIF13A E32 and ARHGEF7 3′UTR). N, normal samples; PM, samples from pre-mutation carriers and DM patients with increasing disease severity. The agarose gel separation of representative RT-PCR products for alternative exon inclusion and exclusion in non-DM (sample 6A, female, tibialis anterior) and DM1 (sample 3A; adult onset, male, tibialis anterior; 390 CTG repeats) is shown.